EmailFacebookXLinkedIn

Lina_S

About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 418 blog entries.

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.

2021-07-29T22:38:03+02:00

Graff JN, Baciarello G, Armstrong AJ, Higano CS, Iversen P, Flaig TW, Forer D, Parli T, Phung D, Tombal B, Beer TM, Sternberg CN. Ann Oncol. 2016 Feb;27(2):286-94. doi: 10.1093/annonc/mdv542. Epub 2015 Nov 16.

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.2021-07-29T22:38:03+02:00

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

2021-10-25T15:43:31+02:00

Lichtman SM, Cirrincione CT, Hurria A, Jatoi A, Theodoulou M, Wolff A, Gralow J, Morganstern DE, Magrinat G, Cohen HJ, Muss HB. J Clin Oncol. 2016 Jan 11. pii: JCO626341. (Journal of Clinical Oncology)

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 499072021-10-25T15:43:31+02:00

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

2021-07-29T22:38:03+02:00

Aparicio T, Lavau-Denes S, Phelip JM, Maillard E, Jouve JL, Gargot D, Gasmi M, Locher C, Adhoute X, Michel P, Khemissa F, Lecomte T, Provençal J, Breysacher G, Legoux JL, Lepère C, Charneau J, Cretin J, Chone L, Azzedine A, Bouché O, Sobhani I, Bedenne L, Mitry E; for FFCD investigators. Ann Oncol. 2016 Jan;27(1):121-7. doi: 10.1093/annonc/mdv491. Epub 2015 Oct 20.

Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)2021-07-29T22:38:03+02:00

A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators.

2021-07-29T22:38:03+02:00

Kenis C, Heeren P, Decoster L, Van Puyvelde K, Conings G, Cornelis F, Cornette P, Moor R, Luce S, Libert Y, Van Rijswijk R, Jerusalem G, Rasschaert M, Langenaeken C, Baitar A, Specenier P, Geboers K, Vandenborre K, Debruyne PR, Vanoverbeke K, Van den Bulck H, Praet JP, Focan C, Verschaeve V, Nols N, Goeminne JC, Petit B, Lobelle JP, Flamaing J, Milisen K, Wildiers H.   J Nutr Health Aging. 2016;20(1):60-70. doi: 10.1007/s12603-015-0538-4.

A Belgian survey on geriatric assessment in oncology focusing on large-scale implementation and related barriers and facilitators.2021-07-29T22:38:03+02:00

The assessment and management of older cancer patients: A SIOG surgical task force survey on surgeons’ attitudes

2021-08-05T08:15:42+02:00

Ghignone F, van Leeuwen BL, Montroni I, Huisman MG, Somasundar P, Cheung KL, Audisio RA, Ugolini G; International Society of Geriatric Oncology (SIOG) Surgical Task Force. Eur J Surg Oncol. 2015 Dec 17. pii: S0748-7983(15)00903-8. doi: 10.1016/j.ejso.2015.12.004. [Epub ahead of print]

The assessment and management of older cancer patients: A SIOG surgical task force survey on surgeons’ attitudes2021-08-05T08:15:42+02:00

Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study

2021-07-29T22:38:03+02:00

Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H. J Geriatr Oncol. 2015 Sep;6(5):401-10. doi: 10.1016/j.jgo.2015.07.005. Epub 2015 Aug 18. (Pubmed)

Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study2021-07-29T22:38:03+02:00

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial

2021-07-29T22:38:05+02:00

Ian H Kunkler, Linda J Williams, Wilma J L Jack, David A Cameron, J Michael Dixon, on behalf of the PRIME II investigators (The Lancet Oncolology)

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial2021-07-29T22:38:05+02:00

Stay in touch and share our news!

SIOG Head Office

  • International Society of Geriatric Oncology
    P/A Comptabilis
    9 route des Jeunes
    1227 Les Acacias - Switzerland

  • +49 30 24603-152
  • enquiry@siog.org

ECOSOC Special

In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).

Quick links

 

Stay in the loop with SIOG’s newsletter!

Subscribe now

Powered by K.I.T. Group – Crafted for Excellence

Go to Top